Walking Interventions to Improve Quality of Life Among Adults with T2D in SA and the UK

NCT05894252 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2025-03-21

No results posted yet for this study

Summary

The research will be conducted as a quantitative experimental study (as an intervention). For the primary DV, quality of life, there are two effective measures.

* Health-related Quality of Life (HRQoL) scales of the SF-36 short form
* Euro-QoL instruments (EQ-5D).

Additionally, secondary variables assessed will be:

* (Physical Activity (the International PA questionnaire, short form - IPAQ)
* General Anxiety (the Generalised Anxiety Disorder Assessment - GAD-7
* Symptoms of Depression (the Patient Health Questionnaire - PHQ-9)
* Habitual diet will be assessed with the EPIC food frequency questionnaire,
* Memory function through the Gorilla online questionnaire (Memory Intrusion - TB1 and TB2).
* Health locus of control (Multidimensional Health Locus of Control form C)

Participants in the intervention group will be required to complete a 30-minute walk five days a week for 12 weeks. This will be in addition to any regular walking or exercise they are currently doing, which will be assessed via questionnaire at baseline. In the control group, participants will be asked to continue with their daily routines and usual level of physical activity.

The baseline measurements will be taken before the intervention at week zero. Subsequently, all the participants will attend a virtual meeting (screening visit) to learn about the key aspects of the research, including the required actions of the control and intervention groups, how to use the act watch and report the required data. All participants in the intervention group and the control group will be required to wear acti-watches, which will be given to them for free.

Participants in both groups will be asked to report the number of steps covered each week. Participants will report this information through an online link provided by the researcher. Each participant will access their data through an app that comes with the watch, however, the researchers will not have access to the app

Conditions

Interventions

OTHER

Walking Interventions

Participants in the intervention group will be required to complete a 30-minute walk five days a week for 12 weeks. This will be in addition to any regular walking or exercise they are currently doing, which will be assessed via a questionnaire at baseline. In the control group, participants will be asked to continue with their daily routines and usual level of physical activity. The baseline measurements will be taken before the intervention at week zero. Subsequently, all the participants will attend a virtual meeting (screening visit) to learn about the key aspects of the research, including the required actions of the control and intervention groups, how to use the act watch and report the required data. All participants in the intervention group and the control group will be required to wear acti watches, which will be given to them for free.

Sponsors & Collaborators

  • University of Reading

    lead OTHER

Principal Investigators

  • Daniel Lamport, PhD · University of Reading

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-14
Primary Completion
2024-03-20
Completion
2024-03-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05894252 on ClinicalTrials.gov